valu usd unless otherwis note
view consensu ep estim rebas believ
compani posit start meet beat consensu
expect believ new leadership unlock valu
share remedi issu north west campus fill
key product gap intern innov acceler
top-line bottom-lin growth
manag feel comfort handl
suppli issu earlier week fda complet inspect
north campu warsaw issu anoth form
letter despit ceo say expect compani
back full suppli key brand begin
confid achiev timelin last quarter
recoveri effort continu without interrupt thu far
de-risk key recoveri mileston new
leadership ad oper
manag provid adjust ep guidanc
consensu midpoint manag expect report
revenu growth fce
expect adjust ep fce believ
revenu growth rbce final manag discuss
higher capit cost pressur near-term howev
believ show slight oper margin expans
new oper margin guidanc fce
reduc ep estim believ estim
bottom revenu estim move higher
y/i constant currenc account favor
fx adjust cash ep move lower y/
due higher oper expens lower
separ revenu estim move higher
y/i constant currenc adjust cash ep
move lower y/i pt move
thesi unchang new leadership unlock valu share
patienc need believ today ep guidanc reduct
expect investor set manag
begin hit sell-sid expect still recommend
long-term investor expect bryan hanson turn around
compani howev patienc need remedi issu
still process fix new manag reinvest
busi drive top-line growth new knee shoulder
robot product ramp throughout addit expect
manag begin focus portfolio manag
increas weight averag market growth rate
price prior trade day market close estimate unless otherwis note
capit market appreci consider institut investor all-america research survey
believ share outperform
peer group follow key reason
believ world-wide recon market larg stabl
given recent commentari orthoped manag
team well surgeon check believ
world-wide recon market larg stabl fact
world-wide recon market growth remain stabl
y/i rang everi year expect
stabl world-wide recon trend continu
 job outlook overal economi continu slowli
improv price pressur remain constant
recent acquisit upcom new product launch
focus fill portfolio gap acceler top-line
growth addit ldrh expand zbh mi portfolio
add fastest-grow cervic disc market
share put compani within strike distanc
separ acquisit med-tech
sa provid robot play orthoped
market final note sever import
new/upcom product launch acceler
cementless knee persona revis system stemless
new leadership unlock valu share
patienc need expect manag begin
hit sell-sid expect still recommend
long-term investor expect bryan hanson
turn around compani howev patienc need
remedi issu still process
fix new manag reinvest busi
drive top-line growth new knee shoulder
expect manag begin focus portfolio
manag increas weight averag
bloomberg capit market estim upside/downside/target
base case scenario price target assum
compani grow top-line in-line market growth rate
medium term assum fda
issu warn letter north campu
base case scenario appli multipl peer
pro-forma adjust dilut cash ep estim
scenario model long-term adjust
cash ep growth slightli peer high-single-digit y/
rang analysi support outperform rate
upsid scenario assum return
top-line growth suppli concern resolv
compani regain surgeon confid launch new
product scenario also assum compani new ceo
bring addit experienc medic devic manag
help lead compani also explor potenti
divestitur sever under-perform busi includ
dental scenario long-term adjust dilut
ep growth could slightli larg cap md
downsid scenario assum compani
grow top-line well market growth rate
owe continu recon share loss on-going pressur
dental bone heal spine busi final call
pure price world-wide recon market take anoth
step scenario long-term adjust cash
ep growth would mid-single-digit y/i
deriv price target appli multipl pro-forma adjust
dilut cash ep estim large-cap med-tech peer believ
discount multipl appropri given lower top-lin growth rel
peer uncertainti regard on-going manufacturing/suppli issu price target
support outperform rate
risk rate price target
impedi achiev price target rate includ company-specif risk
suspens delay launch new product normal industri risk includ
competit depend agent distributor currenc intellectu properti
reimburs slow compani end market clinic trial risk regulatori
inc design develop manufactur market reconstruct
orthopaed implant includ small/larg joint dental spinal implant trauma
product sport medicin product relat orthopaed surgic product
sport extrem trauma
interest expens net
net incom attribut zmh
sport extrem trauma
